ABL/JAK Inhibitors With Chemotherapy and Venetoclax for Ph-like ALL
Institute of Hematology & Blood Diseases Hospital, China
Institute of Hematology & Blood Diseases Hospital, China
M.D. Anderson Cancer Center
Nurix Therapeutics, Inc.
Institute of Hematology & Blood Diseases Hospital, China
Institute of Hematology & Blood Diseases Hospital, China
AstraZeneca
M.D. Anderson Cancer Center
Princess Maxima Center for Pediatric Oncology
Gustave Roussy, Cancer Campus, Grand Paris
The First Affiliated Hospital with Nanjing Medical University
Dalian Medical University
IRCCS San Raffaele
Israeli Medical Association